| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,732 |
35,599 |
$1.51M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,958 |
17,839 |
$1.06M |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
5,660 |
5,424 |
$805K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
15,996 |
6,044 |
$574K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13,880 |
12,859 |
$543K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,269 |
3,091 |
$295K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
8,177 |
3,640 |
$250K |
| 64483 |
|
1,480 |
1,416 |
$143K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
1,790 |
1,271 |
$142K |
| 64635 |
|
224 |
173 |
$33K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
763 |
502 |
$22K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
167 |
161 |
$21K |
| 64636 |
|
362 |
172 |
$19K |
| 64493 |
|
268 |
233 |
$18K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
958 |
849 |
$14K |
| 97161 |
|
188 |
186 |
$13K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
3,280 |
2,609 |
$13K |
| 62321 |
|
92 |
91 |
$9K |
| 97165 |
|
123 |
122 |
$9K |
| 64494 |
|
185 |
161 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
100 |
95 |
$6K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
668 |
584 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
4,917 |
3,756 |
$4K |
| 27096 |
|
38 |
38 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,974 |
2,369 |
$3K |
| 20610 |
|
118 |
104 |
$3K |
| 96127 |
|
1,067 |
945 |
$3K |
| 81025 |
|
485 |
388 |
$2K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
625 |
545 |
$2K |
| 64495 |
|
61 |
51 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
13 |
13 |
$1K |
| 99443 |
|
32 |
24 |
$1K |
| 99442 |
|
59 |
50 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
534 |
489 |
$649.77 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,889 |
2,453 |
$431.17 |
| 99408 |
|
116 |
107 |
$287.79 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
827 |
669 |
$283.81 |
| 83992 |
|
188 |
116 |
$249.03 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
432 |
345 |
$247.91 |
| 77002 |
|
12 |
12 |
$170.33 |
| 80346 |
|
160 |
95 |
$109.68 |
| 80372 |
|
225 |
145 |
$109.68 |
| 80373 |
|
204 |
132 |
$109.68 |
| 80375 |
|
169 |
124 |
$109.68 |
| 80351 |
|
167 |
100 |
$109.68 |
| 80364 |
|
220 |
142 |
$109.68 |
| 80354 |
|
225 |
145 |
$109.68 |
| 80365 |
|
225 |
145 |
$109.68 |
| 80356 |
|
188 |
116 |
$109.68 |
| 80348 |
|
225 |
145 |
$109.68 |
| 80353 |
|
188 |
116 |
$109.68 |
| 80371 |
|
188 |
116 |
$109.68 |
| 80357 |
|
188 |
116 |
$109.68 |
| 80324 |
|
188 |
116 |
$109.68 |
| 80349 |
|
173 |
102 |
$109.68 |
| 80358 |
|
225 |
145 |
$109.68 |
| 99484 |
|
62 |
58 |
$94.26 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,139 |
1,715 |
$88.59 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
954 |
784 |
$54.11 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
34 |
26 |
$0.31 |
| 80321 |
|
100 |
96 |
$0.00 |
| 80369 |
|
49 |
29 |
$0.00 |
| 80339 |
|
91 |
57 |
$0.00 |
| 80360 |
|
73 |
44 |
$0.00 |
| 80355 |
|
77 |
44 |
$0.00 |
| 80366 |
|
77 |
44 |
$0.00 |
| 80359 |
|
176 |
104 |
$0.00 |
| 80368 |
|
77 |
44 |
$0.00 |